RAPGEF1 and lymphoma: In this study, we combined biochemical and cell biology techniques, as well as animal models, to investigate the impact of catalytic deregulation of C3G, specifically the C3G-Y564H mutation in mice (equivalent to the human C3G-Y554H mutation), on lymphoma cell biology.